Cambridge Communication System has received $10m in a funding round that included a $5m commitment from Adtran.

Rabo Ventures has co-led the artificial intelligence-based medical imaging technology developer's $11.3m series A alongside Inkef Capital.

Satt Sud-Est has licensed Yukin Therapeutics to commercialise patents originating from several French institutions on the back of inventions from regional research hub Canceropôle Provence-Alpes-Côte d'Azur.

Charles Conn and Patrick Pichette will join Oxford Sciences Innovation to become chief executive and chairman, respectively, with founder Dave Norwood retiring.

Immunotherapy developer Hookipa, backed by Gilead, Boehringer Ingelheim and Takeda, has collected $37.5m in a series D round led by Redmile Group.

Zurich immuno-oncology spinout Anaveon raised $35.1m from Novartis Venture Fund and Syncona in addition to seed-stage notes converted by the UZH Life Sciences Fund.

Zurich immuno-oncology spinout Anaveon raised $35.1m from Novartis Venture Fund and Syncona in addition to seed-stage notes converted by the UZH Life Sciences Fund.

Russian Academy of Sciences spinout PM&HM has signed up a second government-owned vehicle to help commercialise its digitally-enabled inhaler for tuberculosis, cancer and HIV.

NovaUCD has helped spawn 45 spinouts since 2003 and offered innovation support to companies which generated more than $128m of combined turnover during 2018.

Fraunhofer Venture has unveiled an accelerator for businesses based on its research in areas including artificial intelligence, digital medicine and industry 4.0.